[pp.int.general] Pharm Companies to ignore MRSA cure over patents?

Amelia Andersdotter teirdes at gmail.com
Mon Aug 13 18:46:25 CEST 2007

" Phages are notoriously hard to patent, the process by which drug
companies secure their future profits."

I'm obviously just a common layman, but I would have thought their
future profits would be far more secured by having something to sell?


More information about the pp.international.general mailing list